Gyimesi, G.; Keczer, B.; Rein, P.; Horváth, M.; Gellért, B.; Marjai, T.; Tóth, E.; Szűcs, Á.; Szijártó, A.; Barbai, T.;
et al. Clinical Benefits of KRAS/GNAS Gene Mutation Analysis in Addition to Morphology and Conventional Cyst Fluid Testing in Differentiating Pancreatic Cysts. J. Clin. Med. 2025, 14, 8671.
https://doi.org/10.3390/jcm14248671
AMA Style
Gyimesi G, Keczer B, Rein P, Horváth M, Gellért B, Marjai T, Tóth E, Szűcs Á, Szijártó A, Barbai T,
et al. Clinical Benefits of KRAS/GNAS Gene Mutation Analysis in Addition to Morphology and Conventional Cyst Fluid Testing in Differentiating Pancreatic Cysts. Journal of Clinical Medicine. 2025; 14(24):8671.
https://doi.org/10.3390/jcm14248671
Chicago/Turabian Style
Gyimesi, György, Bánk Keczer, Péter Rein, Miklós Horváth, Bálint Gellért, Tamás Marjai, Enikő Tóth, Ákos Szűcs, Attila Szijártó, Tamás Barbai,
and et al. 2025. "Clinical Benefits of KRAS/GNAS Gene Mutation Analysis in Addition to Morphology and Conventional Cyst Fluid Testing in Differentiating Pancreatic Cysts" Journal of Clinical Medicine 14, no. 24: 8671.
https://doi.org/10.3390/jcm14248671
APA Style
Gyimesi, G., Keczer, B., Rein, P., Horváth, M., Gellért, B., Marjai, T., Tóth, E., Szűcs, Á., Szijártó, A., Barbai, T., Székely, E., & Hritz, I.
(2025). Clinical Benefits of KRAS/GNAS Gene Mutation Analysis in Addition to Morphology and Conventional Cyst Fluid Testing in Differentiating Pancreatic Cysts. Journal of Clinical Medicine, 14(24), 8671.
https://doi.org/10.3390/jcm14248671
